• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ram Mukunda

Recent news which mentions Ram Mukunda

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
November 26, 2024
Tickers IGC NEWS
Tags Alzheimer's cannabinoid/based drug IGC/AD1 alzheimer's
From Benzinga
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
March 20, 2024
Tickers DRUG IGC
Tags IGC Market News Top Stories
From Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
February 19, 2024
Tickers IGC
Tags Earnings Biotech IGC
From Benzinga
Cannabis Based Pain Relief Solution Receives European Patent Approval
October 20, 2023
Tickers IGC
Tags Markets General Cannabinoid Composition and Method for Treating Pain
From Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers POTX TOKE
Tags News Inc/ FDA
From Benzinga
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
July 12, 2023
Tickers IGC
Tags Markets Ram Mukunda Cannabis
From Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
February 15, 2023
Tickers IGC
Tags Cannabis Benzinga Markets
From Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
January 04, 2023
Tickers IGC
Tags premium Market News IGC
From Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
December 01, 2022
Tickers IGC
Tags Benzinga Cannabis Markets
From Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
November 02, 2022
Tickers IGC
Tags Earnings IGC News
From Benzinga
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap